The pharmaceutical industry isn't going to just sit back and take it.
Days after members of a Congressional committee took turns bashing drug executives accused of ripping off consumers, the Pharmaceutical Research and Manufacturers of America, the powerful trade group that represents drug companies, announced it will be amping up its advertising budget in an attempt to dissuade both voters and lawmakers from supporting restrictions on the industry.
The Wall Street Journal reports that the group is already blanketing social media with messages about the benefits of the millions of dollars in medical research undertaken by its member companies, such as Bayer, Pfizer and GlaxoKlineSmith.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
